CPHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
China Pharma Holdings Inc (CPHI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company shows poor financial performance, no positive trading signals, and lacks recent news or catalysts to support a bullish outlook. Additionally, technical indicators and trading trends do not indicate a strong entry point.
The MACD is slightly positive at 0.0212, but the RSI at 46.114 is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.596, with resistance at 0.66 and support at 0.533. Overall, the technical outlook is weak.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
There is no recent news or events to drive positive sentiment.
In Q3 2025, revenue dropped by -31.26% YoY to $756,217, net income fell by -41.72% YoY to -$651,482, EPS declined by -73.85% YoY to -0.17, and gross margin plummeted by -83.29% YoY to -7.89%. The company is facing severe financial challenges.
No analyst rating or price target data available.
